Lisanti Capital Growth, LLC Dyne Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

  • $307 Million
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$23.56 - $35.55 $952,884 - $1.44 Million
40,445 Added 233.65%
57,755 $1.36 Million
Q3 2024

Nov 04, 2024
SELL
$31.94 - $47.04 $2.84 Million - $4.18 Million
-88,830 Reduced 83.69%
17,310 $621,000
Q2 2024

Jul 31, 2024
BUY
$23.65 - $35.63 $461,884 - $695,853
19,530 Added 22.55%
106,140 $3.75 Million
Q1 2024

May 06, 2024
BUY
$13.06 - $29.18 $1.13 Million - $2.53 Million
86,610 New
86,610 $2.46 Million

Others Institutions Holding DYN

# of Institutions
210
Shares Held
122M
Call Options Held
36.5K
Put Options Held
74.3K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $602M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email